Targeting mitochondrial vulnerabilities could help treat triple-negative breast cancer
A deeper understanding of mitochondrial function could create new opportunities for treating triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of breast cancer.
Read original article on The Medical News →Related news
-
Alcohol and the brain interact through immune cells, new research shows
United Kingdom
-
Robotic surgery enables effective and safe repair of hard-to-reach abdominal hernias
United Kingdom
-
Yo-yo dieting may pose different risks depending on starting weight
United Kingdom
-
Had genetic testing for cancer risk years ago? Newer tests may find what old ones missed
United Kingdom
-
Human stem-cell model reveals a shared origin for tissue-resident macrophages
United Kingdom
-
Congo's confirmed Ebola cases exceed 9,000 as containment efforts falter
United Kingdom
-
Vaccine redesign may separate Zika protection from risk of worsening dengue
United Kingdom
-
Stress during pregnancy may change placental signals linked to fetal brain development
United Kingdom